Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) today announced that the peer-reviewed journal, Clinical Pharmacology in Drug Development, has published the results of a clinical trial examining the effect of food on the oral bioavailability of rencofilstat, the Company’s lead drug candidate.
October 20, 2022
· 4 min read